Adial Pharmaceuticals Inc (ADIL)
1.25
-0.17
(-11.97%)
USD |
NASDAQ |
May 23, 16:00
1.25
0.00 (0.00%)
After-Hours: 17:14
Adial Pharmaceuticals Research and Development Expense (Quarterly): 0.4543M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.4543M |
| December 31, 2023 | 0.2644M |
| September 30, 2023 | 0.2071M |
| June 30, 2023 | 0.4299M |
| March 31, 2023 | 0.3656M |
| December 31, 2022 | 0.5318M |
| September 30, 2022 | 0.6961M |
| June 30, 2022 | 0.68M |
| March 31, 2022 | 0.5963M |
| December 31, 2021 | 2.333M |
| September 30, 2021 | 1.692M |
| June 30, 2021 | 2.319M |
| March 31, 2021 | 2.052M |
| December 31, 2020 | 2.064M |
| September 30, 2020 | 1.847M |
| June 30, 2020 | 0.888M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.060M |
| December 31, 2019 | 1.204M |
| September 30, 2019 | 0.8643M |
| June 30, 2019 | 1.210M |
| March 31, 2019 | 0.6869M |
| December 31, 2018 | 0.0476M |
| September 30, 2018 | 0.1884M |
| June 30, 2018 | 0.0769M |
| March 31, 2018 | 0.0555M |
| December 31, 2017 | 0.052M |
| September 30, 2017 | 0.0278M |
| June 30, 2017 | 0.0579M |
| March 31, 2017 | 0.0445M |
| December 31, 2016 | 0.0279M |
| September 30, 2016 | 0.0409M |
| June 30, 2016 | 0.0382M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.2071M
Minimum
Sep 2023
2.333M
Maximum
Dec 2021
1.088M
Average
0.8761M
Median
Research and Development Expense (Quarterly) Benchmarks
| BioVie Inc | 5.700M |
| BioSig Technologies Inc | 0.238M |
| Precision BioSciences Inc | 13.34M |
| Humacyte Inc | 21.26M |
| Monogram Technologies Inc | 2.407M |